Article
Urology & Nephrology
Nicholas H. Chakiryan, Da David Jiang, Kyle A. Gillis, Elizabeth Green, Ali Hajiran, Lee Hugar, Logan Zemp, Jingsong Zhang, Rohit Jain, Jad Chahoud, Michael Poch, Brandon J. Manley, Roger Li, Wade Sexton, Scott M. Gilbert
Summary: The study found that neoadjuvant chemotherapy was associated with pathological downstaging for all histological variants of muscle invasive bladder cancer, and led to improved overall survival for patients with urothelial carcinoma, sarcomatoid variant UC and neuroendocrine carcinoma.
JOURNAL OF UROLOGY
(2021)
Article
Oncology
Se Young Choi, Moon Soo Ha, Byung Hoon Chi, Jin Wook Kim, In Ho Chang, Tae-Hyoung Kim, Soon Chul Myung, Myoungsuk Kim, Kyung-Eun Lee, Yuwon Kim, Hyun-Ki Woo, Dae-Sung Kyoung, Hasung Kim
Summary: This study compared the perioperative outcomes, overall survival, and treatment trends in patients with bladder cancer who underwent radical cystectomy and received either neoadjuvant or adjuvant chemotherapy. The findings suggest that neoadjuvant chemotherapy is associated with better overall survival and lower administration of granulocyte colony-stimulating factor when compared to adjuvant chemotherapy. Therefore, neoadjuvant chemotherapy should be considered as a treatment option for bladder cancer patients undergoing radical cystectomy.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
(2022)
Article
Oncology
Eva Kjeldsted, Julie Gehl, Dina Melanie Sorensen, Alexey Lodin, Silvia Gonzalez Ceballos, Susanne Oksbjerg Dalton
Summary: This study aimed to examine clinical practice patterns and patient-related characteristics associated with treatment modifications in patients with breast cancer undergoing neoadjuvant chemotherapy. It was found that age, comorbidity, long-term medications, and being overweight were significantly associated with treatment modifications. The results highlight the need for supportive care initiatives for older patients or those with comorbidities to improve chemotherapy adherence.
Article
Urology & Nephrology
David D'Andrea, Peter C. Black, Homayoun Zargar, Colin P. Dinney, Francesco Soria, Michael S. Cookson, Jeffrey S. Montgomery, Wassim Kassouf, Marc A. Dall'Era, Srikala S. Sridhar, John S. McGrath, Jonathan L. Wright, Andrew C. Thorpe, Jeff M. Holzbeierlein, Diego M. Carrion, Ettore Di Trapani, Trinity J. Bivalacqua, Scott North, Daniel A. Barocas, Yair Lotan, Petros Grivas, Andrew J. Stephenson, Bas W. van Rhijn, Siamak Daneshmand, Philippe E. Spiess, Shahrokh F. Shariat, Kamran Zargar-Shoshtar, Laura S. Mertens, Adrian S. Fairey, Maria C. Mir, Laura-Maria Krabbe, Niels-Erik Jacobsen, Nikhil Vasdev, Evan Y. Yu, Evanguelos Xylinas, Benjamin Pradere, Renate Pichler, Nicholas J. Campain, Jo-An Seah, Cesar E. Ercole, Simon Horenblas, Jonathan Aning, Todd M. Morgan, Jay B. Shah, Marco Moschini
Summary: This study investigated the pathological response rates and survival outcomes of patients with cT2-4N0M0 muscle invasive bladder cancer who received 3 vs 4 cycles of cisplatin-based neoadjuvant chemotherapy (NAC). The results showed that patients treated with 4 cycles of NAC achieved better pathological response and overall survival compared to those treated with 3 cycles. These findings provide valuable information for clinicians and serve as a benchmark for prospective trials.
JOURNAL OF UROLOGY
(2022)
Article
Oncology
Rom Leidner, Marka Crittenden, Kristina Young, Hong Xiao, Yaping Wu, Marcus A. Couey, Ashish A. Patel, Allen C. Cheng, Amber L. Watters, Carlo Bifulco, George Morris, Lessli Rushforth, Shorin Nemeth, Walter J. Urba, Michael Gough, R. Bryan Bell
Summary: The study demonstrated that the combination of radiation therapy with immunotherapy is safe and effective for patients with HNSCC, resulting in a high rate of pathological response and downstaging. The majority of patients in the study showed tumor pathological responses and clinical to pathological downstaging.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2021)
Article
Oncology
Daniel D. Joyce, Kevin M. Wymer, Vidit Sharma, James P. Moriarty, Bijan J. Borah, Daniel M. Geynisman, Elizabeth R. Plimack, Brian A. Costello, Lance C. Pagliaro, Stephen A. Boorjian
Summary: Neoadjuvant ddMVACx6 was more cost-effective than GCx4 for muscle-invasive bladder cancer.
Correction
Urology & Nephrology
S. Raveenthiran, W. J. Yaxley, T. Franklin, G. Coughlin, M. Roberts, T. Gianduzzo, B. Kua, H. Samaratunga, B. Delahunt, L. Egevad, D. Wong, L. McEwan, N. Brown, R. Parkinson, R. Esler, J. W. Yaxley
Summary: In patients with muscle invasive bladder cancer, cisplatin-based neoadjuvant chemotherapy with 4 cycles achieves better pathological response and survival compared to 3 cycles. These findings are clinically significant and provide a benchmark for future trials.
JOURNAL OF UROLOGY
(2022)
Article
Medicine, General & Internal
Hyung Sun Kim, Kenji Nakagawa, Takahiro Akahori, Kota Nakamura, Tadataka Takagi, Masayuki Sho, Joon Seong Park, Dong Sup Yoon
Summary: A comparative study on neoadjuvant treatment in clinical T1 stage pancreatic cancer patients found no significant difference in overall survival compared to upfront surgery. Large-scale prospective studies are required to determine the survival benefits of neoadjuvant treatment for early-stage pancreatic cancer.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Oncology
Marta Casarrubios, Mariano Provencio, Ernest Nadal, Amelia Insa, Maria Del Rosario Garcia-Campelo, Martin Lazaro-Quintela, Manuel Domine, Margarita Majem, Delvys Rodriguez-Abreu, Alex Martinez-Marti, Javier De Castro Carpeno, Manuel Cobo, Guillermo Lopez Vivanco, Edel Del Barco, Reyes Bernabe, Nuria Vinolas, Isidoro Barneto Aranda, Bartomeu Massuti, Belen Sierra-Rodero, Cristina Martinez-Toledo, Ismael Fernandez-Miranda, Roberto Serna-Blanco, Atocha Romero, Virginia Calvo, Alberto Cruz-Bermudez
Summary: In this study, the gene expression profile of tumor samples was analyzed to identify new biomarkers and mechanisms behind tumor responses to neoadjuvant chemoimmunotherapy and disease recurrence after surgery.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2022)
Article
Genetics & Heredity
Lu Sun, Ziping Wu, Yanping Lin, Shuguang Xu, Yumei Ye, Wenjin Yin, Liheng Zhou, Jingsong Lu
Summary: This study aimed to investigate the relationship between single nucleotide polymorphisms (SNPs) in the gamma-glutamyltransferase 1 (GGT1) gene and the response to neoadjuvant chemotherapy (NAC) in breast cancer patients. Results showed that certain genotypes of the selected SNPs were associated with different treatment responses and adverse events, indicating a potential role of GGT1 gene SNPs as an independent risk factor for poor NAC response in breast cancer patients.
BMC MEDICAL GENOMICS
(2023)
Article
Oncology
O. Gluz, S. Kuemmel, U. Nitz, M. Braun, K. Luedtke-Heckenkamp, R. von Schumann, M. Darsow, H. Forstbauer, J. Potenberg, C. Uleer, E. M. Grischke, B. Aktas, C. Schumacher, C. zu Eulenburg, R. Kates, K. Jozwiak, M. Graeser, R. Wuerstlein, R. Baehner, M. Christgen, H. H. Kreipe, N. Harbeck
Summary: In high-risk HR+/HER2- early breast cancer, nanoparticle albumin-bound (nab)-paclitaxel showed promising efficacy versus solvent-based (sb)-paclitaxel in neoadjuvant trials. However, optimal patient and therapy selection remains a topic of ongoing research.
ANNALS OF ONCOLOGY
(2023)
Article
Oncology
Yuchun Wei, Chuqing Wei, Liang Chen, Ning Liu, Qiuxiang Ou, Jiani C. Yin, Jiaohui Pang, Zhenhao Fang, Xue Wu, Xiaonan Wang, Dianbin Mu, Yang Shao, Jinming Yu, Shuanghu Yuan
Summary: This study analyzed the genetic alterations in locally advanced cervical cancer patients who received neoadjuvant therapy and found differences in gene mutation frequency between Asian and Caucasian cohorts. High tumor mutation burden, TP53 polymorphism, and KEAP1 mutations were associated with poor treatment response, while KEAP1 mutations, PIK3CA-SOX2 co-amplification, TERC copy number gain, and TYMS polymorphism correlated with an increased risk of disease relapse.
CANCER RESEARCH AND TREATMENT
(2022)
Article
Urology & Nephrology
Jong Hyun Tae, Moon Soo Ha, Byung Hoon Chi, In Ho Chang, Tae-Hyoung Kim, Soon Chul Myung, Tuan Thanh Nguyen, Myoungsuk Kim, Kyung-Eun Lee, Yuwon Kim, Hyun-Ki Woo, Dae-Sung Kyoung, Hasung Kim, Se Young Choi
Summary: This study evaluated the trends of adjuvant chemotherapy (AC) and neoadjuvant chemotherapy (NAC) in UTUC patients who underwent NUx and compared their perioperative outcomes and overall survival (OS). The study found an increasing trend in the use of NUx without perioperative chemotherapy and no significant difference in perioperative outcomes and OS between NAC and AC groups.
Article
Medicine, Research & Experimental
Lu Guo, Wei Wang, Xiaodong Xie, Shuihua Wang, Yudong Zhang
Summary: The RF model accurately predicted the response to platinum-based NACT in LACC patients. The polymorphic loci rs4558508 and rs7259541 in Akt2, and rs1130233 in Akt1 were important variables for NACT inefficiency.
BIOMEDICINE & PHARMACOTHERAPY
(2023)
Review
Oncology
Van Tai Nguyen, Sabine Winterman, Margot Playe, Amelie Benbara, Laurent Zelek, Frederic Pamoukdjian, Guilhem Bousquet
Summary: This article used a meta-analysis to study the effectiveness of dose-intense cisplatin-based neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer. The results showed that this treatment could improve overall survival and open up new possibilities for clinical trials in cases where local treatment is suboptimal.
Article
Surgery
Elisabeth Jacomine Lier, Barend A. W. van den Beukel, Larsa Gawria, Philip J. van der Wees, Leontine van den Hil, Nicole D. Bouvy, Ying Cheong, Rudy-Leon de Wilde, Harry van Goor, Martijn W. J. Stommel, Richard P. G. ten Broek
Summary: The study developed a new clinical adhesion score (CLAS) to measure the overall clinical morbidity of adhesion-related complications in abdominal and pelvic surgery. Through Delphi study and pilot study, the CLAS includes 22 outcomes and 23 weight factors, correcting the likelihood of symptoms being related to adhesions through scoring.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
(2021)
Article
Oncology
Hee Seung Kim, Sang-Yoon Park, Chan-Yong Park, Young Tae Kim, Beob-Jong Kim, Yong Jung Song, Byoung-Gie Kim, Yong Beom Kim, Chi-Heum Cho, Jong-Hyeok Kim, Yong Sang Song
Summary: This Phase 2b study compared the efficacy and toxicity of belotecan and topotecan in recurrent ovarian cancer, showing that belotecan was not inferior to topotecan in terms of overall response rate. Additionally, belotecan was associated with improved overall survival compared with topotecan, especially in patients with PRROC and non-HGSC. Toxicity did not differ significantly between the two treatment groups.
BRITISH JOURNAL OF CANCER
(2021)
Article
Plant Sciences
In Sil Park, Youngjin Han, HyunA Jo, Ki Won Lee, Yong Sang Song
Summary: Resveratrol and piceatannol, major stilbene compounds found in natural foods, exhibit inhibitory effects on lipid accumulation and adipogenesis, with piceatannol showing superior anti-adipogenic properties compared to resveratrol in a model of visceral obesity.
Article
Oncology
Suhyun Hwangbo, Se Ik Kim, Ju-Hyun Kim, Kyung Jin Eoh, Chanhee Lee, Young Tae Kim, Dae-Shik Suh, Taesung Park, Yong Sang Song
Summary: The study aimed to develop machine learning models predicting platinum sensitivity in patients with high-grade serous ovarian carcinoma (HGSOC). Six variables associated with platinum sensitivity were selected using clinical data from multiple hospitals, and the LR-based model was found to perform the best. A web-based nomogram was developed for clinical use based on the LR model results.
Article
Oncology
Chae Young Han, David A. Patten, Se Ik Kim, Jung Jin Lim, David W. Chan, Michelle K. Y. Siu, Youngjin Han, Euridice Carmona, Robin J. Parks, Cheol Lee, Li-Jun Di, Zhen Lu, Karen K. L. Chan, Ja-Lok Ku, Elizabeth A. Macdonald, Barbara C. Vanderhyden, Anne-Marie Mes-Masson, Hextan Y. S. Ngan, Annie N. Y. Cheung, Yong Sang Song, Robert C. Bast, Mary-Ellen Harper, Benjamin K. Tsang
Summary: This study highlights the functional interaction between HKII and activated P-p53 (Ser15) in the regulation of bioenergetics and chemosensitivity, emphasizing the increased nuclear HKII-P-p53 (Ser15) interaction as a potential prognostic biomarker in ovarian cancer.
Article
Oncology
Se Ik Kim, Sungyoung Lee, Chel Hun Choi, Maria Lee, Dong Hoon Suh, Hee Seung Kim, Kidong Kim, Hyun Hoon Chung, Jae Hong No, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song, Yong Beom Kim
Summary: The study developed models predicting survival outcomes according to the surgical approach for radical hysterectomy in early cervical cancer, with hybrid ensemble models performing the best.
Review
Cell Biology
Revathy Nadhan, Ciro Isidoro, Yong Sang Song, Danny N. Dhanasekaran
Summary: This review summarizes the structure and function of long non-coding RNAs (lncRNAs) in cellular signaling networks, as well as their mechanisms of action. It provides insights into the pathogenesis of cardiovascular diseases, neurological disorders, cancers, and diabetes mellitus, highlighting the role of lncRNAs. The review suggests that lncRNAs could be potential therapeutic targets.
Review
Oncology
Panagiotis A. Konstantinopoulos, Antonio Gonzalez-Martin, Felipe Melo Cruz, Michael Friedlander, Rosalind Glasspool, Domenica Lorusso, Christian Marth, Bradley J. Monk, Jae-Weon Kim, Patsy Hinson, Olga Ajipa, Vincent Pretre, Yu Han, Ursula A. Matulonis
Summary: This article describes a study investigating the combination of the specific phosphatidylinositol-3-kinase (PI3K) inhibitor alpelisib and the poly (adenosine diphosphateribose) polymerase (PARP) inhibitor olaparib in platinum-resistant or -refractory high-grade serous ovarian cancer (HGSOC) patients without germline BRCA mutation. The study aims to improve the prognosis of patients with this condition.
Article
Oncology
David Tan, Noriko Fujiwara, Keiichi Fujiwara, Philip Beale, Jae-Weon Kim, Joseph Ng, Se Ik Kim, Alison Evans, Byoung-Gie Kim
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
(2023)
Article
Oncology
Soseul Sung, Youjin Hong, Byoung-Gie Kim, Ji-Yeob Choi, Jae Weon Kim, Sang-Yoon Park, Jae-Hoon Kim, Yong-man Kim, Jong-Min Lee, Tae Jin Kim, Sue K. K. Park
Summary: This study aimed to verify the association between ovarian cancer (OC) and reproductive- and lifestyle-related risk factors stratified by the subtype of OC. The results showed that smoking was positively associated with high-grade serous (HGS) OC, alcohol consumption was positively associated with mucinous type (MUC), and obesity was associated with clear cell type (CLC). Further, spontaneous abortion was negatively associated with CLC, while tubal ligation, hysterectomy, and oophorectomy were associated with decreased risk of HGS. Early menarche was strongly associated with increased risk of CLC. Additionally, childbirth, oral contraceptives, and hormone replacement therapy were negatively associated with OC.
Review
Biochemistry & Molecular Biology
Revathy Nadhan, Srishti Kashyap, Ji Hee Ha, Muralidharan Jayaraman, Yong Sang Song, Ciro Isidoro, Danny N. Dhanasekaran
Summary: Peritoneal cancers pose significant challenges in clinical practice and have a poor prognosis. Understanding cancer cell metabolism and cancer-promoting metabolites in peritoneal cancers can provide new insights into tumor progression mechanisms, identify therapeutic targets and biomarkers, and improve treatment outcomes for patients.
Article
Cell Biology
Rebecca Yun, Eunji Hong, Junil Kim, Bora Park, Staci Jakyong Kim, Bona Lee, Yong Sang Song, Seong-Jin Kim, Sujin Park, Jin Muk Kang
Summary: This study reveals the crucial role of N-linked glycosylation in the functional post-translational modification of KIAA1324, which is important for suppressing cancer cell proliferation and migration in gastric cancer. Inhibition of glycosylation and fucosylation also inhibits KIAA1324-induced cell growth inhibition and apoptosis. Additionally, the study shows that N-linked glycosylation decreases protein stability through rapid proteasomal degradation. Overall, this research highlights the significance of post-translational modifications in KIAA1324 for gastric cancer progression.
CELL DEATH & DISEASE
(2023)
Article
Oncology
Jung-Yun Lee, Byoung-Gie Kim, Jae-Weon Kim, Jung Bok Lee, Eunhyang Park, Je-Gun Joung, Sunghoon Kim, Chel Hun Choi, Hee Seung Kim
Summary: This study is an umbrella trial for platinum-resistant ovarian cancer, using biomarkers to determine patients' treatment. The results showed that all treatment combinations were manageable and clinically beneficial.
JOURNAL OF GYNECOLOGIC ONCOLOGY
(2022)
Review
Oncology
Jeong-Yeol Park, Jung-Yun Lee, Yoo-Young Lee, Seung-Hyuk Shim, Dong Hoon Suh, Jae-Weon Kim
Summary: This review summarizes the major clinical research advances in gynecologic oncology, including treatment modalities and drug research for cervical cancer, ovarian cancer, and uterine corpus cancer. The study findings demonstrate the effectiveness and survival outcomes of new treatment strategies and drugs for these cancers.
JOURNAL OF GYNECOLOGIC ONCOLOGY
(2022)
Review
Oncology
Yoo-Young Lee, Min Chul Choi, Jeong-Yeol Park, Dong Hoon Suh, Jae-Weon Kim
Summary: The review summarized major clinical research advances in gynecologic oncology in 2020, covering treatment progress and prevention strategies for cervical, ovarian, and uterine corpus cancers.
JOURNAL OF GYNECOLOGIC ONCOLOGY
(2021)